MRNA – moderna, inc. (US:NASDAQ)
Stock Stats
News
Moderna (NASDAQ:MRNA) was given a new $28.00 price target on by analysts at Morgan Stanley.
Moderna (NASDAQ:MRNA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating on the stock.
Global AI Infrastructure Shift Ignites Biotech Growth Phase
Moderna (NASDAQ:MRNA) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Form 144 Moderna, Inc. Filed by: Flagship Pioneering Inc.
Form 4 Moderna, Inc. For: Dec 09 Filed by: Hussain Abbas
Form 144 Moderna, Inc. Filed by: Hussain Abbas
Form 4 Moderna, Inc. For: Dec 05 Filed by: Mock James M
Form 4 Moderna, Inc. For: Dec 05 Filed by: Klinger Shannon Thyme
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.